Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107883

The Central Nervous System as a Site of Action for the Coronary Vasoconstrictor Effect of Digoxin

Hasan Garan, Thomas W. Smith, and Wm. John Powell Jr.

Cardiac Unit, Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of the Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of Harvard Medical School, Boston, Massachusetts 02114

Find articles by Garan, H. in: PubMed | Google Scholar

Cardiac Unit, Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of the Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of Harvard Medical School, Boston, Massachusetts 02114

Find articles by Smith, T. in: PubMed | Google Scholar

Cardiac Unit, Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of the Massachusetts General Hospital, Boston, Massachusetts 02114

Department of Medicine of Harvard Medical School, Boston, Massachusetts 02114

Find articles by Powell, W. in: PubMed | Google Scholar

Published December 1, 1974 - More info

Published in Volume 54, Issue 6 on December 1, 1974
J Clin Invest. 1974;54(6):1365–1372. https://doi.org/10.1172/JCI107883.
© 1974 The American Society for Clinical Investigation
Published December 1, 1974 - Version history
View PDF
Abstract

Digitalis is known to have a vasoconstrictor effect in the coronary circulation. Recent studies have demonstrated that the coronary vasoconstrictor effects of acetylstrophanthidin and digoxin are neurally mediated via alpha adrenergic fibers. In the present study, experiments were done in 20 dogs anesthetized with chloralose and urethane to study the central nervous system as a possible site of action for this vasoconstrictor effect of digoxin. After the intravenous administration of 1.0 mg digoxin, cerebrospinal fluid concentrations of digoxin rose to a peak of 2.3±0.4 (SEM) ng/ml at 15 min, temporally corresponding to the peak in coronary vascular resistance change of +20.0±2.5% of control in the paced canine heart. Submicrogram digoxin injections into the lateral cerebral ventricle produced a significant increase in coronary vascular resistance, the latter injection producing a peak increase in coronary vascular resistance of 12.4±1.2% of control. Cross-perfusion experiments, where the isolated head of the operative dog was perfused from a donor dog receiving digoxin, thus keeping digoxin levels in the remainder of the operative dog very low, showed a similar degree of coronary vasoconstriction. Thus, the central nervous system appears to be an important site of action for the early coronary vasoconstrictor effect of digoxin.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1365
page 1365
icon of scanned page 1366
page 1366
icon of scanned page 1367
page 1367
icon of scanned page 1368
page 1368
icon of scanned page 1369
page 1369
icon of scanned page 1370
page 1370
icon of scanned page 1371
page 1371
icon of scanned page 1372
page 1372
Version history
  • Version 1 (December 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts